Dermata Therapeutics (DRMA) Stock Chart & Stock Price History $0.72 +0.01 (+0.85%) As of 09:52 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dermata Therapeutics Stock Price Performance The Dermata Therapeutics (DRMA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 68.60%, with a year-to-date return of -46.96%. In the past month, the stock has increased 0.52%, reflecting recent market activity. As of the latest close, Dermata Therapeutics traded at $0.71 with a market cap of $4.53 million and volume of 168,566 shares. Receive DRMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.19%1 Month Performance+0.52%3 Month Performance-11.55%Year-To-Date Performance-46.96%1 Year Performance-68.60% DRMA Stock Chart for Monday, July, 14, 2025 DRMA Chart by TradingView Dermata Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$0.72$0.71-1.35%$0.78$0.69168,566 shs$4.53 million07/10/2025$0.65$0.72+10.76%$0.72$0.6670,673 shs$4.59 million07/09/2025$0.63$0.65+3.14%$0.71$0.6379,915 shs$4.15 million07/08/2025$0.70$0.63-9.35%$0.68$0.61705,708 shs$4.02 million07/07/2025$0.67$0.70+4.35%$0.74$0.64156,415 shs$4.24 million07/04/2025$0.67$0.67$0.70$0.6542,072 shs$4.25 million07/03/2025$0.67$0.67-0.15%$0.70$0.6542,072 shs$4.25 million07/02/2025$0.64$0.67+4.12%$0.69$0.6488,484 shs$4.26 million07/01/2025$0.59$0.64+9.50%$0.65$0.5968,315 shs$4.09 million06/30/2025$0.60$0.59-3.21%$0.63$0.5950,410 shs$3.73 million Get the Latest News and Ratings for DRMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$0.59$0.60+3.14%$0.61$0.5981,564 shs$3.86 million06/26/2025$0.63$0.59-6.33%$0.63$0.57103,125 shs$3.74 million06/25/2025$0.63$0.63-0.70%$0.63$0.60110,893 shs$3.99 million06/24/2025$0.63$0.63-0.32%$0.65$0.61139,965 shs$4.02 million06/23/2025$0.68$0.63-6.48%$0.68$0.6361,676 shs$4.03 million06/20/2025$0.69$0.68-2.64%$0.68$0.66113,374 shs$4.31 million06/19/2025$0.69$0.69$0.72$0.65132,909 shs$4.43 million06/18/2025$0.71$0.69-1.91%$0.72$0.65132,909 shs$4.43 million06/17/2025$0.70$0.71+1.09%$0.73$0.6847,329 shs$4.51 million06/16/2025$0.71$0.70-1.73%$0.71$0.6950,049 shs$4.47 million06/13/2025$0.73$0.71-2.96%$0.73$0.7032,711 shs$4.54 million Related Companies NKGN Stock Chart CASI Stock Chart LEXX Stock Chart ALLR Stock Chart EDSA Stock Chart BFRG Stock Chart SYBX Stock Chart RLYB Stock Chart ASBP Stock Chart IMNN Stock Chart Receive DRMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DRMA) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dermata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
